[Rational bases of the use of arterial bypasses in coronary surgery. II. Biochemical-pharmacological evidence].
Parolari
A
A
Cattedra di Cardiochirurgia I, Università degli Studi, Centro Cardiologico Fondazione I Monzino, IRCCS, Milano.
Antona
C
C
Alamanni
F
F
Gerometta
P
P
Rona
P
P
Pompilio
G
G
Sala
A
A
Biglioli
P
P
D016718:Arachidonic Acid / Q000378:metabolism; D001158:Arteries / Q000187:drug effects / Q000378:metabolism / Q000637:transplantation*; D001779:Blood Coagulation Factors; D006152:Cyclic GMP / Q000096:biosynthesis; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D011464:Epoprostenol / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009204:Myocardial Revascularization; D010277:Parasympathomimetics / Q000494:pharmacology; D015539:Platelet Activation; D012501:Saphenous Vein / Q000187:drug effects / Q000378:metabolism / Q000637:transplantation; D013268:Stimulation, Chemical
D001779:Blood Coagulation Factors; D010277:Parasympathomimetics; D016718:Arachidonic Acid; D011464:Epoprostenol; D006152:Cyclic GMP
Fondamenti razionali per l'impiego dei condotti arteriosi nella chirurgia coronarica. Parte II: evidenze biochimico-farmacologiche.